Hexacath

medical devices

About

Hexacath is a French medical device company established in 1994, specializing in innovative vascular therapy products for interventional cardiology. The company focuses on treating acute coronary syndromes, including myocardial infarction, with advanced medical devices such as bioactive coronary stents and various PTCA and PTA catheters for both coronary and peripheral vascular applications. Among its notable products is the TiTAN OPTIMAX bioactive coronary stent, which won the Prix Galien 2021 award for its effectiveness. Hexacath also offers Bare Metal Stents and a range of catheters designed for precise vascular interventions. The company is dedicated to supporting interventional cardiologists globally, emphasizing evidence-based practices and continuous innovation in medical devices. Hexacath operates in multiple regions, including Europe, the Middle East, the Americas, and Asia, and is recognized for its commitment to enhancing patient care in interventional cardiology through clinical excellence and technology-driven solutions.

Technologies

YouTube Google Tag Manager Mobile Friendly WordPress.org Data Analytics AI

Keywords

medical equipment manufacturing myocardial infarction treatment in vivo studies fda clearance bioactive stent coronary lesion crossing medical devices cardiovascular devices european medical device company cardiology healthcare equipment & supplies percutaneous intervention coronary stent coronary lesions treatment key opinion leader partnerships bioactive coating healing promotion randomized controlled trials minoca diagnosis coronary artery disease acs treatment anti-inflammatory properties interventional cardiology devices anoca assessment bioactive coating technology microcatheter titanium-nitride-oxide coating in vitro studies rayflow microcatheter cardiovascular device

Location

4 Passage Saint-Antoine, Rueil-Malmaison, Ile-de-France, France, 92500

Related Companies

Companies in the same industry